Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakez Kayed

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Biochemistry and Biophysics Reports|March 28, 2024
Characterization of α-synuclein oligomers formed in the presence of lipid vesiclesAnvesh K R Dasari, Urmi Sengupta, Elizabeth Viverette, et al.
Brain Research|May 25, 2005
Oligomeric proteins ultrastructurally localize to cell processes, especially to axon terminals with higher density, but not to lipid rafts in Tg2576 mouse brainHideko Kokubo, Rakez Kayed, Charles G Glabe, et al.
The Journal of Biological Chemistry|May 23, 2006
ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice culturesYoung Hae Chong, Yoo Jeong Shin, Eun Ok Lee, et al.
Protein Science : a Publication of the Protein Society|August 21, 2018
Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behaviorGaurav Ghag, Nemil Bhatt, Daniel V Cantu, et al.
Acta Neuropathologica Communications|June 15, 2014
Characterization of tau oligomeric seeds in progressive supranuclear palsyJulia E Gerson, Urmi Sengupta, Cristian A Lasagna-Reeves, et al.
Journal of Neurochemistry|November 9, 2011
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseasesZane S Martin, Volker Neugebauer, Kelly T Dineley, et al.
Biochemistry|November 5, 2010
Preparation and characterization of neurotoxic tau oligomersCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Marcos J Guerrero-Muoz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2005
Reversal of amyloid-induced heart disease in desmin-related cardiomyopathyAtsushi Sanbe, Hanna Osinska, Chet Villa, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 30, 2025
Characterization of conformation-specific antibodies TOMA-1 and TTCM-1 for recombinant tau monomer and amplified brain derived tau oligomerMd Anzarul Haque, Mauro Montalbano, Sheeza Khan, et al.
Molecular Neurodegeneration|June 8, 2011
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type miceCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Urmi Sengupta, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Biochemistry and Biophysics Reports|March 28, 2024
Characterization of α-synuclein oligomers formed in the presence of lipid vesiclesAnvesh K R Dasari, Urmi Sengupta, Elizabeth Viverette, et al.
Brain Research|May 25, 2005
Oligomeric proteins ultrastructurally localize to cell processes, especially to axon terminals with higher density, but not to lipid rafts in Tg2576 mouse brainHideko Kokubo, Rakez Kayed, Charles G Glabe, et al.
The Journal of Biological Chemistry|May 23, 2006
ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice culturesYoung Hae Chong, Yoo Jeong Shin, Eun Ok Lee, et al.
Protein Science : a Publication of the Protein Society|August 21, 2018
Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behaviorGaurav Ghag, Nemil Bhatt, Daniel V Cantu, et al.
Acta Neuropathologica Communications|June 15, 2014
Characterization of tau oligomeric seeds in progressive supranuclear palsyJulia E Gerson, Urmi Sengupta, Cristian A Lasagna-Reeves, et al.
Journal of Neurochemistry|November 9, 2011
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseasesZane S Martin, Volker Neugebauer, Kelly T Dineley, et al.
Biochemistry|November 5, 2010
Preparation and characterization of neurotoxic tau oligomersCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Marcos J Guerrero-Muoz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2005
Reversal of amyloid-induced heart disease in desmin-related cardiomyopathyAtsushi Sanbe, Hanna Osinska, Chet Villa, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 30, 2025
Characterization of conformation-specific antibodies TOMA-1 and TTCM-1 for recombinant tau monomer and amplified brain derived tau oligomerMd Anzarul Haque, Mauro Montalbano, Sheeza Khan, et al.
Molecular Neurodegeneration|June 8, 2011
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type miceCristian A Lasagna-Reeves, Diana L Castillo-Carranza, Urmi Sengupta, et al.
Pageof 21